← Back to Search

Skills for Human Immunodeficiency Virus Infection

Phase 1
Waitlist Available
Led By Christie J. Rizzo, Ph.D.
Research Sponsored by Rhode Island Hospital
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be younger than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline, 3 months, 6 months, 9 months
Awards & highlights

Study Summary

This project is designed to develop and test a group-based preventive intervention to reduce dating violence and sexual risk behavior among adolescent females with prior dating violence exposure.

Eligible Conditions
  • Human Immunodeficiency Virus Infection
  • Dating Abuse

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline, 3 months, 6 months, 9 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline, 3 months, 6 months, 9 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change in number (#) of unprotected sex acts
Secondary outcome measures
Change in number of acts of dating violence perpetration and victimization

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: SkillsExperimental Treatment1 Intervention
Cognitive-Behavioral Dating Violence and HIV Prevention Group
Group II: Health PromotionActive Control1 Intervention
Psycho-educational Dating Violence and HIV Prevention group

Find a Location

Logistics

Participation is compensated

You will be compensated for participating in this trial.

Who is running the clinical trial?

Rhode Island HospitalLead Sponsor
260 Previous Clinical Trials
66,907 Total Patients Enrolled
Christie J. Rizzo, Ph.D.Principal InvestigatorRhode Island Hospital

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
~6 spots leftby Apr 2025